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Despite numerous cases of human infection with 
Streptococcus suis worldwide, human disease is rarely di-
agnosed in North America. We studied 73 swine-exposed 
and 67 non–swine-exposed US adults for antibodies to 
S. suis serotype 2. Serologic data suggest that human in-
fection with S. suis occurs more frequently than currently 
documented.
S
treptococcus suis is one of the most important patho-
gens affecting the swine industry. The gram-positive, 
encapsulated bacterium causes a wide range of clinical dis-
ease syndromes in pigs and other domestic animals. De-
spite the recognition that S. suis infection may result in a 
life-threatening meningitis or toxic-shock syndrome, little 
is known about human pathogenesis. A recent outbreak in 
People’s Republic of China caused by a serotype 2 strain 
resulted in 38 deaths among 215 infected humans, an 18% 
mortality rate (1). The bacterium has caused sporadic hu-
man illness in other countries as well, including the United 
Kingdom (2), and has been identiﬁ  ed as a leading cause of 
bacterial meningitis in Hong Kong Special Administrative 
Region (3) and Vietnam (4). 
Although human infection with S. suis has been occa-
sionally documented in North America (5), the ﬁ  rst human 
case was not reported in the United States until 2006, when 
a farmer from New York sought treatment for meningitis. 
The source was an area farm where the patient had recently 
purchased piglets (6). Several investigators have suggested 
that the infrequent diagnosis of human S. suis infection is 
due to underdiagnosis or misdiagnosis, rather than a true 
absence of disease (5,7,8).
The Study
To test the hypothesis that human infections with S. 
suis occur more commonly than currently recognized, we 
examined archived serum samples from 73 swine-exposed 
and 67 non–swine-exposed adults living in Iowa (9). These 
persons had all previously completed occupational history 
questionnaires detailing their pig exposure and use of per-
sonal protective gear. Use of materials was approved by the 
Institutional Review Board at the University of Iowa. An-
tibodies to serotype 2 S. suis were measured by an ELISA 
that used whole S. suis cells (serotype 2, strain 30–336–06) 
as antigen (10).
The ELISA optical density readings for the 73 swine-
exposed study participants and 67 non–swine-exposed par-
ticipants were ﬁ  rst compared to the positive-control mean 
option density read per plate per dilution. Optical densities 
greater or equal to mean positive-control optical density 
were considered positive. To be conservative, the titer was 
deﬁ  ned as the last positive dilution before the ﬁ  rst negative. 
Again, when a conservative approach was used, the lowest 
titer among duplicates was considered as the ﬁ  nal antibody 
titer. We used the Fisher exact test to test the null hypoth-
esis that the exposed group does not have higher incidence 
of antibody titer >10 than the non–swine-exposed group 
does. We tested a similar hypothesis for speciﬁ  c risk groups 
exposed to swine (such as nursing or ﬁ  nishing swine, use of 
gloves) compared with groups not exposed to swine. Risk 
factor analyses were performed with exact logistic regres-
sion. Seven (9.6%) of 73 swine-exposed study participants 
were positive, and 1 (1.5%) of the 67 non–swine-exposed 
participants was positive. 
Study participants who work with both ﬁ  nishing and 
nursery swine had 8.8× the odds of having a titer >10 when 
compared to nonexposed study participants (exact 95% 
conﬁ  dence interval 1.1–406.3). We identiﬁ  ed no positive 
persons in the group that worked solely with nursery swine, 
a somewhat unexpected ﬁ  nding because most S. suis dis-
ease occurs in young pigs. However, our study had rela-
tively few persons who worked exclusively with nursery 
swine (11/73); most participants worked with both nursery 
and ﬁ  nishing swine. Additionally, no farm-level data on 
prevalence of S. suis where these persons were employed 
were collected; therefore, whether those persons worked 
on farms where S. suis had been conﬁ  rmed is not known. 
Other factors such as age, gender, use of tobacco products, 
and use of gloves when working with animals were not sta-
tistically signiﬁ  cant (Table).
Discussion
In this cross-sectional pilot study, we found that more 
swine-exposed persons had higher titers of antibodies to S. 
suis than did non–swine-exposed persons. These data sug-
gest that human infection with S. suis is more common in 
the United States than currently thought. 
Two possible reasons stand out regarding the lack of 
human S. suis disease in the United States. One possibility 
is underdiagnosis or misdiagnosis, rather than a true ab-
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reports showing that S. suis has been mistaken for entero-
cocci, Listeria spp., viridans streptococcus, or Streptococ-
cus pneumoniae (7,8,11). Because of this potential mis-
classiﬁ  cation, previous publications have asserted that S. 
suis should be considered in the differential diagnosis of 
septicemia, especially when complicated by meningitis in 
adults with a recent history of contact with pigs or unpro-
cessed pork (12).
A second possibility is that S. suis strains colonizing 
swine in the United States may be less virulent than Asian 
strains and therefore unlikely to cause overt human disease 
even when transferred between species. This possibility is 
supported by molecular analyses showing that many US 
strains belong to sequence type (ST) 25, whereas most vir-
ulent serotype 2 isolates have been ST1 (13). Finally, these 
hypotheses are not mutually exclusive; both underdiag-
nosis/misdiagnosis and the circulation of lower-virulence 
strains may be occurring, resulting in fewer diagnoses of 
human S. suis infections in North America (11). 
S. suis infection is an important occupational disease 
in humans in many countries. In research conducted in S. 
suis–endemic countries, the annual incidence of S. suis 
meningitis was ≈3 cases/100,000 swine-exposed people: 
roughly 1,500× higher than the rate in the nonexposed 
population (14). Because of this risk, it has been recom-
mended that persons in daily contact with pigs or pig meat 
should use protective gloves to avoid skin trauma and sub-
sequent risk for exposure to the bacterium. Because no 
human vaccine against S. suis exists, suitable preventive 
measures coupled with education and supervision of those 
who come in contact with live swine or unprocessed pork 
are important to decrease the transmission of this organ-
ism to humans. However, few studies have been conducted 
to detect subclinical cases of S. suis infection; therefore, 
the true incidence of infection among the swine-exposed 
is unknown. 
Because our ﬁ  ndings only examined 1 serotype of S. 
suis, our results may not accurately reﬂ  ect antibody preva-
lence. Because we used a whole-cell ELISA, some anti-
body reactions may be due to cross-reacting antibodies to 
other serotypes of S. suis or other species of Streptococcus. 
However, using a slightly different method and population, 
other investigators found a higher seroprevalence, particu-
larly among farmers and meat inspectors (15). This differ-
ence may stem partly from the fact that we used a conser-
vative criterion for considering a sample positive, which 
may further underestimate seroprevalence in our group. 
For example, 4 study participants (3 swine exposed) were 
classiﬁ  ed as having a titer <10 because the ﬁ  rst dilution 
(1:10) was negative in 1 repeat test. However, these partici-
pants’ serum samples were repeatedly positive in the other 
7 dilutions. Acquisition of human positive control serum as 
a standard to test our assay would enable us to make more 
deﬁ  nitive comparisons. 
Finally, because the samples analyzed for this pilot 
study were not collected to speciﬁ  cally assess S. suis infec-
tions, more deﬁ  nitive future prospective studies seem indi-
cated. One limitation of this serologic study is that it does 
not enable us to distinguish antibodies generated as a result 
of true infection versus exposure to S. suis antigens present 
in manure or dust in the facility, for example. Additionally, 
because the questionnaire did not include information on 
pork consumption or handling of raw pork, those factors 
could not be examined as potential risks. Future studies 
might include targeted questionnaires, attempts of bacterial 
isolation, and serial sera collections to examine serologic 
evidence of infection. 
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